Europe Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,000	73 Pages	The Insight Partners	September, 2022	TIP17466369

Best Price Guarantee
Price	from $3,000
Length	73 Pages
Publisher	The Insight Partners
Published Date	September, 2022
SKU	TIP17466369

Europe Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)

The mid-size pharmaceutical market in Europe is expected to grow from US$ 201,707.89 million in 2022 to US$ 288,168.27 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
The mid-size pharmaceutical market in Europe is characterized by the presence of various market players. To increase their market share, the players adopt various strategies such as product launches, regional expansion, and technological advancements. Leading players invest in R&D to develop advanced technologies and gain revenue. Europe accounts for the second-largest market share and is anticipated to register a significant growth rate over the forecast period. The market growth in this region is attributed to the increasing number of product launches and the growing prevalence of chronic diseases. Further, increased government expenditures on the healthcare sector favor the entry of new players in the mid-size pharmaceutical market in this region. However, the cutthroat competition among market players hinders the market growth.
By introducing new features and technologies, vendors in the Europe mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.
Europe Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)
Europe Mid-Size Pharmaceutical Market Segmentation
The Europe mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the Europe mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the Europe mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the Europe mid-size pharmaceutical market is segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Germany held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Eisai Co., Ltd.; Endo Pharmaceuticals Inc.; Les Laboratories Servier; Mallinckrodt; Regeneron Pharmaceuticals, Inc; Sun Pharmaceutical Industries Ltd; and UCB S.A. are among the leading companies operating in the mid-size pharmaceutical market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe mid-size pharmaceutical market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe mid-size pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the mid-size pharmaceutical market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution"

1. Introduction: 1.1 Scope of the Study; 1.2 The Insight Partners Research Report Guidance; 1.3 Market Segmentation; 1.3.1 Europe Mid-Size Pharmaceutical – By Type; 1.3.2 Europe Mid-Size Pharmaceutical – By Drug Development Type; 1.3.3 Europe Mid-Size Pharmaceutical – By Formulation; 1.3.4 Europe Mid-Size Pharmaceutical – By Therapy Area; 1.3.5 Europe Mid-Size Pharmaceutical – By Country
2. Mid-Size Pharmaceutical– Key Takeaways
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. Europe Mid-Size Pharmaceutical – Market Landscape: 4.1 Overview; 4.2 Europe PEST Analysis; 4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics: 5.1 Market Drivers; 5.1.1 Increasing Prevalence of Chronic Disorders; 5.1.2 Increasing Product Approval and Launches; 5.2 Market Restraints; 5.2.1 Cutthroat Competition among Market Players; 5.3 Market Opportunities; 5.3.1 Rising Number of Healthcare Start-ups; 5.4 Future Trends; 5.4.1 Greater Focus on R&D; 5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– Europe Analysis: 6.1 Europe Mid-Size Pharmaceutical Market Revenue Forecast and Analysis
7. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type: 7.1 Overview; 7.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028); 7.3 Prescription; 7.3.1 Overview; 7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 7.4 Over-the-Counter (OTC); 7.4.1 Overview; 7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Mid-Size Pharmaceutical Market Analysis – By Drug Development Type: 8.1 Overview; 8.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028); 8.3 In-House; 8.3.1 Overview; 8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 8.4 Outsource; 8.4.1 Overview; 8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Mid-Size Pharmaceutical Market – By Formulation: 9.1 Overview; 9.2 Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%); 9.3 Tablets and Capsules; 9.3.1 Overview; 9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 9.4 Injectables; 9.4.1 Overview; 9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 9.5 Sprays; 9.5.1 Overview; 9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 9.6 Other Formulations; 9.6.1 Overview; 9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Mid-Size Pharmaceutical Market – By Therapy Class: 10.1 Overview; 10.2 Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%); 10.3 Cardiovascular Diseases; 10.3.1 Overview; 10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.4 Pain Management; 10.4.1 Overview; 10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.5 Diabetes; 10.5.1 Overview; 10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.6 Cancer; 10.6.1 Overview; 10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.7 Other Diseases; 10.7.1 Overview; 10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis: 11.1 Overview; 11.1.1 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%); 11.1.1.1 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.1 Overview; 11.1.1.1.2 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.3 Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.1.1.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.1 Overview; 11.1.1.2.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.3 France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.5 France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.1.1.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.1 Overview; 11.1.1.3.2 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.3 UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.1.1.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.1 Overview; 11.1.1.4.2 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.3 Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.1.1.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.1 Overview; 11.1.1.5.2 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.3 Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.1.1.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.1 Overview; 11.1.1.6.2 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.1.1.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
12. Mid-Size Pharmaceutical Market–Industry Landscape: 12.1 Overview; 12.2 Growth Strategies Done by the Companies in the Market, (%); 12.3 Organic Developments; 12.3.1 Overview; 12.4 Inorganic Developments; 12.4.1 Overview
13. Company Profiles: 13.1 DAIICHI SANKYO COMPANY LIMITED; 13.1.1 Key Facts; 13.1.2 Business Description; 13.1.3 Products and Services; 13.1.4 Financial Overview; 13.1.5 SWOT Analysis; 13.1.6 Key Developments; 13.2 Eisai Co., Ltd.; 13.2.1 Key Facts; 13.2.2 Business Description; 13.2.3 Products and Services; 13.2.4 Financial Overview; 13.2.5 SWOT Analysis; 13.2.6 Key Developments; 13.3 Bausch Health Companies Inc.; 13.3.1 Key Facts; 13.3.2 Business Description; 13.3.3 Products and Services; 13.3.4 Financial Overview; 13.3.5 SWOT Analysis; 13.3.6 Key Developments; 13.4 Regeneron Pharmaceuticals, Inc; 13.4.1 Key Facts; 13.4.2 Business Description; 13.4.3 Products and Services; 13.4.4 Financial Overview; 13.4.5 SWOT Analysis; 13.4.6 Key Developments; 13.5 Sun Pharmaceutical Industries Ltd; 13.5.1 Key Facts; 13.5.2 Business Description; 13.5.3 Products and Services; 13.5.4 Financial Overview; 13.5.5 SWOT Analysis; 13.5.6 Key Developments; 13.6 Alexion Pharmaceuticals, Inc.; 13.6.1 Key Facts; 13.6.2 Business Description; 13.6.3 Products and Services; 13.6.4 Financial Overview; 13.6.5 SWOT Analysis; 13.6.6 Key Developments; 13.7 Mallinckrodt; 13.7.1 Key Facts; 13.7.2 Business Description; 13.7.3 Products and Services; 13.7.4 Financial Overview; 13.7.5 SWOT Analysis; 13.7.6 Key Developments; 13.8 Endo Pharmaceuticals Inc.; 13.8.1 Key Facts; 13.8.2 Business Description; 13.8.3 Products and Services; 13.8.4 Financial Overview; 13.8.5 SWOT Analysis; 13.8.6 Key Developments; 13.9 Les Laboratories Servier; 13.9.1 Key Facts; 13.9.2 Business Description; 13.9.3 Products and Services; 13.9.4 Financial Overview; 13.9.5 SWOT Analysis; 13.9.6 Key Developments; 13.10 UCB S.A.; 13.10.1 Key Facts; 13.10.2 Business Description; 13.10.3 Products and Services; 13.10.4 Financial Overview; 13.10.5 SWOT Analysis; 13.10.6 Key Developments
14. Appendix: 14.1 About The Insight Partners; 14.2 Glossary of Terms
LIST OF TABLES: Table 1. Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 2. Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 3. Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 4. Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 5. France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 6. France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 7. France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 8. France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 9. UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 10. UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 11. UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 12. UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 13. Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 14. Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 15. Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 16. Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 17. Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 18. Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 19. Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 20. Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 21. Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 22. Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 23. Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 24. Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 25. Organic Developments Done By Companies; Table 26. Inorganic Developments Done By Companies; Table 27. Glossary of Terms
LIST OF FIGURES: Figure 1. Europe Mid-Size Pharmaceutical Segmentation; Figure 2. Europe Mid-Size Pharmaceutical Segmentation, By Country; Figure 3. Europe Mid-Size Pharmaceutical Overview; Figure 4. Over-the-Counter Segment Held Largest Share by Type in Europe Mid-Size Pharmaceutical Market; Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period; Figure 6. Europe: PEST Analysis; Figure 7. Europe Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028; Figure 8. Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028); Figure 9. Europe Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 10. Europe Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 11. Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028); Figure 12. Europe In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 13. Europe Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 14. Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%); Figure 15. Europe Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 16. Europe Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 17. Europe Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 18. Europe Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 19. Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%); Figure 20. Europe Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 21. Europe Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 22. Europe Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 23. Europe Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 24. Europe Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 25. Europe: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2021) (US$ Million); Figure 26. Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%); Figure 27. Percentage of people aged 65+ reporting chronic diseases are as follows: (Source: European Commission (2019a), Joint report on health care); Figure 28. Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 29. France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 30. UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 31. Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 32. Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 33. Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); Figure 34. Growth Strategies Done by the Companies in the Market, (%)